Congenital metatarsus primus varus, unspecified foot
ICD-10 Q66.219 is a billable code used to indicate a diagnosis of congenital metatarsus primus varus, unspecified foot.
Congenital metatarsus primus varus is a foot deformity characterized by an abnormal angulation of the first metatarsal bone, leading to a varus position of the great toe. This condition is often present at birth and can result in functional limitations and cosmetic concerns. The etiology is multifactorial, including genetic predispositions and environmental influences during fetal development. Diagnosis is typically made through clinical examination, where the foot may appear to have a curved shape, and the great toe is angled towards the midline. Treatment options vary based on severity and may include conservative measures such as stretching exercises, orthotic devices, or surgical intervention in more severe cases. Accurate coding is essential for appropriate management and reimbursement, particularly in pediatric populations where early intervention can significantly improve outcomes.
Documentation should include detailed clinical findings, treatment plans, and follow-up assessments specific to pediatric patients.
Common scenarios include newborn assessments for foot deformities and follow-up visits for treatment efficacy.
Consideration of growth and development milestones in relation to the condition is crucial for accurate coding.
Genetic evaluations may be necessary to rule out syndromic associations with congenital foot deformities.
Genetic counseling sessions for families with a history of congenital malformations.
Documentation should include any genetic testing results that may influence treatment decisions.
Used in cases where surgical intervention is necessary for severe deformity.
Surgical reports and pre-operative assessments must be documented.
Pediatric orthopedic specialists should provide detailed operative notes.
Accurate coding is crucial for ensuring appropriate treatment plans, facilitating research on congenital conditions, and securing proper reimbursement for healthcare services. It also aids in tracking the prevalence and outcomes of congenital malformations.
